Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares

● . ● Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares October 09, 2024 7:58 AM EDT | Source: Cardiol Therapeutics Inc. Oakville, Ontario--(Newsfile Corp. - October 9, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, announced today the pricing of its previously announce ...